PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
IsraelRecruitingPHASE4
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Beta Lactam Resistant Bacterial Infection · Enterobacteriaceae Infections · Bacteremia
Locations
- University of Calgary, Cumming School of Medicine, O'Brien Institute for Public Health, Calgary, Alberta, Canada
- Surrey Memorial Hospital - Fraser Health Authority, Surrey, British Columbia, Canada
- Eastern Health, St. John's, Newfoundland and Labrador, Canada
- Kingston General Hospital, Kingston, Ontario, Canada
- Jewish Genral Hospital, Montreal, Quebec, Canada
- McGill University Health Centre, Montreal, Quebec, Canada
- Rambam Health Care Campus, Haifa, Israel, Israel
- Soroka Medical Center, Beersheba, Israel
- Hadassah Medical Center, Jerusalem, Israel
- Meir Medical Center, Kfar Saba, Israel
- Sanz Medical Center-Laniado Hospital, Netanya, Israel
- Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel
- Sheba Medical Center (Tel HaShomer), Tel Aviv, Israel
- Sourasky Medical Center, Tel Aviv, Israel